Evidence map›Paper›PMID 23616647›Full record

ArticleJournal of virology2013

Modulation of GB virus B RNA abundance by microRNA-122: dependence on and escape from microRNA-122 restriction.

Selena M Sagan, Peter Sarnow, Joyce A Wilson

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Selena M SaganDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA. smsagan@stanford.edu
Peter Sarnow
Joyce A Wilson
Stanford University · USUniversity of Saskatchewan · CA

Funding

Roles for microRNA-122 in hepatitis C virus RNA amplificationR01AI069000 · NIAID · STANFORD UNIVERSITY · PI SARNOW, PETER · 2006 to 2022
$6.2M
Structure and Function of the Hepatitis C Virus GenomeR37AI047365 · NIAID · STANFORD UNIVERSITY · PI SARNOW, PETER · 2011 to 2019
$4.0M
THE PROKARYOTIC-LIKE IRES IN HCV AS A DRUG TARGETR01AI047365 · NIAID · STANFORD UNIVERSITY · PI PUGLISI, JOSEPH D, SARNOW, PETER · 1999 to 2010
$3.8M
CIHRNIAID NIH HHS AI 069000NIAID NIH HHS AI 47365NIAID NIH HHS R01 AI047365NIAID NIH HHS R01 AI069000NIAID NIH HHS R37 AI047365
6 · The paper itself

Abstract

Hepatitis C virus (HCV) RNA forms an unusual interaction with human microRNA-122 (miR-122) that promotes viral RNA accumulation in cultured human liver cells and in the livers of infected chimpanzees. GB virus B (GBV-B) is a hepatotropic virus and close relative of HCV. Thus, GBV-B has been used as a surrogate system to study HCV amplification in cultured cells and in infected tamarins. It was discovered that the 5'-terminal sequences of GBV-B RNA, like HCV RNA, forms an Argonaute 2-mediated complex with two miR-122 molecules that are essential for accumulation of GBV-B subgenomic replicon RNA. However, sequences in miR-122 that anneal to each viral RNA genome were different, suggesting distinct overall structural features in HCV:miR-122 and GBV-B:miR-122 complexes. Surprisingly, a deletion that removed both miR-122 binding sites from the subgenomic GBV-B RNAs rendered viral RNA amplification independent from miR-122 and Argonaute 2. This finding suggests that structural features at the end of the viral genome dictate whether miR-122 is required to aid in maintaining viral RNA abundance.

Indexed as

Argonaute ProteinsBlotting, NorthernCell Line, TumorDNA PrimersGB virus BGene Expression Regulation, ViralHepacivirusHumansLuciferasesMicroRNAsMutagenesisPlasmidsReal-Time Polymerase Chain ReactionRepliconRNA, ViralTransfectionAGO2 protein, humanArgonaute ProteinsDNA PrimersLuciferasesMicroRNAsMIRN122 microRNA, humanRNA, Viral

Identifiers

PMID23616647
PMCPMC3700295
OpenAlexW2118441017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.